Cash flow Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
138.99 ^USD	-2.18%		-0.52%	+13.24%

04-10	Cantor Fitzgerald Adjusts Price Target on Gilead Sciences to $115 From $155, Maintains Overweight Rating	MT
04-09	Tempus AI, Inc. And Gilead Sciences, Inc. Announce Strategic Collaboration To Advance Oncology R&D	CI

224c512506a80ca159513c00d3db4._I-uttfOqWIfGBkYg-gyxrgC3o95TsfE1QI6cm34DRM.kcDb2pT78BgnXGBS7o5djsA6s_oDAZijj3hcEAaaW0rF9sfErYbxA1RMVA

Published financial data: GILEAD SCIENCES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	27.3B	27.28B	27.12B	28.75B	29.44B
Other Revenues, Total	-	-	-	-	1M
Total Revenues	27.3B	27.28B	27.12B	28.75B	29.44B
Cost of Goods Sold, Total	5.53B	5.66B	6.02B	6.25B	6.23B
Gross Profit	21.78B	21.62B	21.1B	22.5B	23.21B
Selling General & Admin Expenses, Total	5.25B	5.67B	5.54B	6B	5.71B
R&D Expenses	5.36B	4.98B	5.76B	5.82B	5.69B
Other Operating Expenses, Total	10.61B	10.65B	11.3B	11.82B	11.4B
Operating Income	11.17B	10.97B	9.8B	10.69B	11.82B
Interest Expense, Total	-1B	-935M	-944M	-977M	-1.02B
Interest And Investment Income	-	-	376M	281M	349M
Net Interest Expenses	-1B	-935M	-568M	-696M	-675M
Currency Exchange Gains (Loss)	21M	-21M	-21M	14M	-29M
Other Non Operating Income (Expenses)	-50M	97M	11M	-15M	27M
EBT, Excl. Unusual Items	10.14B	10.12B	9.22B	9.99B	11.14B
Restructuring Charges	-	-	-527M	-189M	-138M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-610M	-657M	-167M	-274M	451M
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-177M	-3.64B	-1.2B	-8.84B	-1.61B
Legal Settlements	-1.08B	-	-525M	-	-
Other Unusual Items	-	-	60M	7M	-43M
EBT, Incl. Unusual Items	8.28B	5.81B	6.86B	691M	9.8B
Income Tax Expense	2.08B	1.25B	1.25B	211M	1.29B
Earnings From Continuing Operations	6.2B	4.57B	5.61B	480M	8.51B
Net Income to Company	6.2B	4.57B	5.61B	480M	8.51B
Minority Interest	24M	26M	52M	-	-
Net Income - (IS)	6.22B	4.59B	5.66B	480M	8.51B
Net Income to Common Incl Extra Items	6.22B	4.59B	5.66B	480M	8.51B
Net Income to Common Excl. Extra Items	6.22B	4.59B	5.66B	480M	8.51B
Per Share Items
Net EPS - Basic	4.96	3.66	4.54	0.38	6.84
Basic EPS - Continuing Operations	4.96	3.66	4.54	0.38	6.84
Basic Weighted Average Shares Outstanding	1.26B	1.26B	1.25B	1.25B	1.24B
Net EPS - Diluted	4.93	3.64	4.5	0.38	6.78
Diluted EPS - Continuing Operations	4.93	3.64	4.5	0.38	6.78
Diluted Weighted Average Shares Outstanding	1.26B	1.26B	1.26B	1.26B	1.26B
Normalized Basic EPS	5.06	5.06	4.66	5.01	5.6
Normalized Diluted EPS	5.04	5.03	4.62	4.98	5.55
Dividend Per Share	2.84	2.92	3	3.08	3.16
Payout Ratio	57.91	80.77	67.24	816.25	47.04
Supplemental Items
EBITDA	13.22B	13.08B	12.5B	13.45B	14.58B
EBITA	12.89B	12.75B	12.14B	13.07B	14.21B
EBIT	11.17B	10.97B	9.8B	10.69B	11.82B
EBITDAR	13.38B	13.24B	12.66B	13.62B	14.75B
Total Revenues (As Reported)	27.3B	27.28B	27.12B	28.75B	29.44B
Effective Tax Rate - (Ratio)	25.09	21.47	18.18	30.54	13.13
Current Domestic Taxes	2B	2.57B	1.86B	1.53B	871M
Current Foreign Taxes	185M	232M	381M	519M	256M
Total Current Taxes	2.19B	2.8B	2.24B	2.05B	1.13B
Deferred Domestic Taxes	-65M	-1.66B	-956M	-1.95B	234M
Deferred Foreign Taxes	-47M	101M	-39M	106M	-75M
Total Deferred Taxes	-112M	-1.56B	-995M	-1.84B	159M
Normalized Net Income	6.36B	6.35B	5.82B	6.24B	6.96B
Interest on Long-Term Debt	1B	940M	-	-	-
Supplemental Operating Expense Items
Advertising Expense	735M	778M	826M	869M	1B
Selling and Marketing Expenses	735M	778M	826M	869M	1B
Research And Development Expense From Footnotes	5.54B	8.62B	6.92B	14.75B	7.41B
Net Rental Expense, Total	156M	162M	165M	163M	169M
Imputed Operating Lease Interest Expense	42.06M	45.65M	48.42M	48.09M	52.38M
Imputed Operating Lease Depreciation	114M	116M	117M	115M	117M
Stock-Based Comp., COGS (Total)	40M	46M	57M	61M	60M
Stock-Based Comp., R&D Exp. (Total)	287M	285M	377M	458M	433M
Stock-Based Comp., SG&A Exp. (Total)	308M	313M	361M	450M	401M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	635M	644M	795M	969M	894M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.34B	5.41B	6.08B	9.99B	7.56B
Short Term Investments	2.63B	1.45B	2.26B	1.58B	2.05B
Total Cash And Short Term Investments	7.96B	6.86B	8.35B	11.57B	9.61B
Accounts Receivable, Total	4.49B	4.78B	4.66B	4.42B	4.91B
Other Receivables	-	-	-	-	-
Total Receivables	4.49B	4.78B	4.66B	4.42B	4.91B
Inventory	1.62B	1.51B	1.79B	1.71B	1.77B
Prepaid Expenses	622M	1.24B	1.28B	480M	899M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	75M	60M	7M	995M	1.14B
Total Current Assets	14.77B	14.44B	16.08B	19.17B	18.34B
Gross Property Plant And Equipment	7.56B	8.17B	8.35B	8.4B	8.83B
Accumulated Depreciation	-1.89B	-2.19B	-2.45B	-2.47B	-2.7B
Net Property Plant And Equipment	5.66B	5.98B	5.9B	5.93B	6.14B
Long-term Investments	2.84B	2.61B	2.16B	327M	3.75B
Goodwill	8.33B	8.31B	8.31B	8.31B	8.31B
Other Intangibles, Total	33.46B	28.89B	26.45B	19.95B	16.98B
Deferred Tax Assets Long-Term	-	-	-	-	1.96B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	2.89B	2.93B	3.22B	5.3B	3.53B
Total Assets	67.95B	63.17B	62.12B	59B	59.02B
Liabilities
Accounts Payable, Total	705M	905M	550M	833M	715M
Accrued Expenses, Total	7B	6.53B	5B	5.12B	5.64B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	1.52B	2.27B	1.8B	1.82B	2.81B
Current Portion of Leases	101M	111M	125M	113M	102M
Current Income Taxes Payable	539M	959M	1.21B	1.65B	92M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	1.75B	455M	2.6B	2.48B	2.46B
Total Current Liabilities	11.61B	11.24B	11.28B	12B	11.81B
Long-Term Debt	25.18B	22.96B	23.19B	24.9B	22.13B
Long-Term Leases	489M	467M	546M	498M	503M
Deferred Tax Liability Non Current	4.36B	2.67B	1.59B	724M	402M
Other Non Current Liabilities	5.25B	4.63B	2.77B	1.63B	1.56B
Total Liabilities	46.89B	41.96B	39.38B	39.75B	36.4B
Common Stock, Total	1M	1M	1M	1M	1M
Additional Paid In Capital	4.66B	5.55B	6.5B	7.7B	8.93B
Retained Earnings	16.32B	15.69B	16.3B	11.5B	13.73B
Comprehensive Income and Other	83M	2M	28M	132M	39M
Total Common Equity	21.07B	21.24B	22.83B	19.33B	22.7B
Minority Interest	-5M	-31M	-84M	-84M	-84M
Total Equity	21.06B	21.21B	22.75B	19.25B	22.62B
Total Liabilities And Equity	67.95B	63.17B	62.12B	59B	59.02B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.25B	1.25B	1.25B	1.25B	1.24B
ECS Total Common Shares Outstanding	1.25B	1.25B	1.25B	1.25B	1.24B
Book Value / Share	16.8	17.03	18.33	15.51	18.29
Tangible Book Value	-20.72B	-15.97B	-11.94B	-8.93B	-2.59B
Tangible Book Value Per Share	-16.52	-12.81	-9.58	-7.17	-2.09
Total Debt	27.28B	25.81B	25.66B	27.32B	25.54B
Net Debt	18.01B	17.7B	16.14B	15.75B	12.95B
Debt Equivalent Oper. Leases	1.25B	1.3B	1.32B	1.3B	1.35B
Minority Interest, Total (Incl. Fin. Div)	-5M	-31M	-84M	-84M	-84M
Equity Method Investments, Total	338M	-	-	-	393M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	404M	562M	561M	561M	561M
Buildings, Total	3.79B	4.39B	4.33B	4.54B	4.62B
Machinery, Total	1.76B	1.99B	2.22B	2.28B	1.24B
Full Time Employees	14.4K	17K	18K	17.6K	17K
Accumulated Allowance for Doubtful Accounts (Supple)	47M	55M	56M	52M	41M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.22B	4.59B	5.66B	480M	8.51B
Depreciation & Amortization - CF	329M	323M	354M	381M	370M
Amortization of Goodwill and Intangible Assets - (CF)	1.72B	1.78B	2.34B	2.39B	2.39B
Depreciation & Amortization, Total	2.05B	2.1B	2.69B	2.77B	2.76B
(Gain) Loss on Sale of Investments - (CF)	610M	657M	167M	274M	-451M
Asset Writedown & Restructuring Costs	177M	3.64B	1.2B	8.84B	1.61B
Stock-Based Compensation (CF)	635M	637M	766M	835M	894M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	1.2B	-798M	-187M	-1.49B	640M
Change In Accounts Receivable	313M	-406M	157M	139M	-367M
Change In Inventories	11M	-310M	-842M	-426M	-1.04B
Change In Accounts Payable	-118M	226M	-347M	290M	-132M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	-364M	-568M	-1.77B	-732M	-
Change In Deferred Taxes	-	-	-	-	-2.11B
Change in Other Net Operating Assets	647M	-705M	497M	-151M	-305M
Cash from Operations	11.38B	9.07B	8.01B	10.83B	10.02B
Capital Expenditure	-579M	-728M	-585M	-523M	-563M
Cash Acquisitions	-1.4B	-1.8B	-1.15B	-4.84B	-1.07B
Investment in Marketable and Equity Securities, Total	-987M	60M	-528M	1.86B	-3.16B
Other Investing Activities, Total	-163M	-1M	0	58M	3M
Cash from Investing	-3.13B	-2.47B	-2.26B	-3.45B	-4.79B
Long-Term Debt Issued, Total	-	-	1.98B	3.46B	-
Total Debt Issued	-	-	1.98B	3.46B	-
Long-Term Debt Repaid, Total	-4.75B	-1.5B	-2.25B	-1.97B	-1.79B
Total Debt Repaid	-4.75B	-1.5B	-2.25B	-1.97B	-1.79B
Issuance of Common Stock	169M	309M	232M	422M	408M
Repurchase of Common Stock	-546M	-1.4B	-1B	-1.15B	-1.92B
Common Dividends Paid	-3.6B	-3.71B	-3.81B	-3.92B	-4B
Common & Preferred Stock Dividends Paid	-3.6B	-3.71B	-3.81B	-3.92B	-4B
Other Financing Activities, Total	-145M	-173M	-278M	-281M	-440M
Cash from Financing	-8.88B	-6.47B	-5.12B	-3.43B	-7.74B
Foreign Exchange Rate Adjustments	-35M	-63M	57M	-40M	92M
Net Change in Cash	-659M	74M	673M	3.91B	-2.43B
Supplemental Items
Cash Interest Paid	979M	907M	891M	951M	1.04B
Cash Income Tax Paid (Refund)	2.51B	3.14B	3.99B	2.78B	3.22B
Levered Free Cash Flow	10.29B	6.94B	8.79B	10.13B	7.54B
Unlevered Free Cash Flow	10.91B	7.52B	9.38B	10.74B	8.18B
Change In Net Working Capital	-1.82B	1.36B	-354M	-849M	2.3B
Net Debt Issued / Repaid	-4.75B	-1.5B	-270M	1.49B	-1.79B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.24	10.46	9.78	11.03	12.52
Return on Total Capital	14.15	14.38	12.84	14.07	15.59
Return On Equity %	31.57	21.6	25.54	2.29	40.66
Return on Common Equity	31.7	21.71	25.71	2.28	40.49
Margin Analysis
Gross Profit Margin %	79.76	79.26	77.8	78.26	78.84
SG&A Margin	19.21	20.79	20.42	20.87	19.39
EBITDA Margin %	48.42	47.93	46.08	46.79	49.51
EBITA Margin %	47.21	46.75	44.77	45.46	48.25
EBIT Margin %	40.91	40.23	36.15	37.17	40.14
Income From Continuing Operations Margin %	22.71	16.74	20.7	1.67	28.9
Net Income Margin %	22.8	16.83	20.89	1.67	28.9
Net Avail. For Common Margin %	22.8	16.83	20.89	1.67	28.9
Normalized Net Income Margin	23.3	23.27	21.45	21.71	23.65
Levered Free Cash Flow Margin	37.67	25.42	32.43	35.23	25.61
Unlevered Free Cash Flow Margin	39.96	27.56	34.6	37.36	27.78
Asset Turnover
Asset Turnover	0.4	0.42	0.43	0.47	0.5
Fixed Assets Turnover	4.84	4.69	4.57	4.86	4.88
Receivables Turnover (Average Receivables)	5.82	5.89	5.75	6.33	6.31
Inventory Turnover (Average Inventory)	3.35	3.62	3.65	3.58	3.58
Short Term Liquidity
Current Ratio	1.27	1.29	1.43	1.6	1.55
Quick Ratio	1.07	1.04	1.15	1.33	1.23
Operating Cash Flow to Current Liabilities	0.98	0.81	0.71	0.9	0.85
Days Sales Outstanding (Average Receivables)	62.73	62.01	63.51	57.79	57.85
Days Outstanding Inventory (Average Inventory)	109.02	100.82	99.88	102.38	102.06
Average Days Payable Outstanding	51.77	52.98	42.16	40.99	44.89
Cash Conversion Cycle (Average Days)	119.98	109.85	121.23	119.17	115.03
Long Term Solvency
Total Debt/Equity	129.53	121.68	112.79	141.96	112.92
Total Debt / Total Capital	56.43	54.89	53	58.67	53.03
LT Debt/Equity	121.86	110.44	104.33	131.94	100.06
Long-Term Debt / Total Capital	53.09	49.82	49.03	54.53	46.99
Total Liabilities / Total Assets	69	66.43	63.38	67.38	61.68
EBIT / Interest Expense	11.16	11.74	10.38	10.94	11.54
EBITDA / Interest Expense	13.36	14.16	13.41	13.94	14.4
(EBITDA - Capex) / Interest Expense	12.78	13.38	12.79	13.4	13.85
Total Debt / EBITDA	2.04	1.95	2.03	2.01	1.73
Net Debt / EBITDA	1.35	1.34	1.28	1.16	0.88
Total Debt / (EBITDA - Capex)	2.13	2.06	2.12	2.09	1.8
Net Debt / (EBITDA - Capex)	1.41	1.42	1.34	1.2	0.91
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.6	-0.09	-0.6	6.04	2.4
Gross Profit, 1 Yr. Growth %	3.72	-0.71	-2.44	6.41	3.16
EBITDA, 1 Yr. Growth %	4.12	-6.47	-4.3	11.92	8.35
EBITA, 1 Yr. Growth %	3.88	-6.58	-4.65	12.05	8.67
EBIT, 1 Yr. Growth %	-0.42	-8.03	-10.51	14.57	10.57
Earnings From Cont. Operations, 1 Yr. Growth %	6.87K	-26.37	22.93	-91.45	1.67K
Net Income, 1 Yr. Growth %	4.96K	-26.23	23.37	-91.53	1.67K
Normalized Net Income, 1 Yr. Growth %	-3.35	-7.16	-8.17	13.1	11.51
Diluted EPS Before Extra, 1 Yr. Growth %	4.94K	-26.17	23.63	-91.56	1.68K
Accounts Receivable, 1 Yr. Growth %	-8.16	6.32	-2.45	-5.15	11.15
Inventory, 1 Yr. Growth %	-3.86	-6.86	18.58	-4.31	3.74
Net Property, Plant and Equip., 1 Yr. Growth %	0.89	5.6	-1.37	0.53	3.52
Total Assets, 1 Yr. Growth %	-0.67	-7.04	-1.66	-5.04	0.05
Tangible Book Value, 1 Yr. Growth %	-10.05	-22.93	-25.26	-25.16	-71
Common Equity, 1 Yr. Growth %	15.75	0.81	7.5	-15.34	17.44
Cash From Operations, 1 Yr. Growth %	39.37	-20.31	-11.75	35.25	-7.47
Capital Expenditures, 1 Yr. Growth %	-10.92	25.73	-19.64	-10.6	7.65
Levered Free Cash Flow, 1 Yr. Growth %	26.57	-32.03	27.03	19.23	-25.57
Unlevered Free Cash Flow, 1 Yr. Growth %	24.82	-30.56	25	18.21	-23.84
Dividend Per Share, 1 Yr. Growth %	4.41	2.82	2.74	2.67	2.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.29	5.12	-0.35	2.66	4.2
Gross Profit, 2 Yr. CAGR %	10.69	1.48	-1.58	2.01	4.77
EBITDA, 2 Yr. CAGR %	10.94	2.53	-5.47	1.43	10.12
EBITA, 2 Yr. CAGR %	10.87	2.45	-5.7	1.24	10.35
EBIT, 2 Yr. CAGR %	9.37	0.07	-9.36	-1.32	12.55
Earnings From Cont. Operations, 2 Yr. CAGR %	7.52	616.26	-4.86	-67.58	23.13
Net Income, 2 Yr. CAGR %	7.51	511.01	-4.6	-67.67	22.56
Normalized Net Income, 2 Yr. CAGR %	6.31	-0.57	-7.77	-0.82	12.3
Diluted EPS Before Extra, 2 Yr. CAGR %	8.09	509.91	-4.46	-67.69	22.75
Accounts Receivable, 2 Yr. CAGR %	12	-1.18	1.84	-3.81	2.68
Inventory, 2 Yr. CAGR %	32.47	-5.37	5.09	6.52	-0.36
Net Property, Plant and Equip., 2 Yr. CAGR %	4.66	3.22	2.05	-0.43	2.01
Total Assets, 2 Yr. CAGR %	5.01	-3.9	-4.38	-3.36	-2.53
Tangible Book Value, 2 Yr. CAGR %	111.72	-16.74	-24.1	-25.21	-53.42
Common Equity, 2 Yr. CAGR %	-3.29	8.02	4.1	-4.6	-0.29
Cash From Operations, 2 Yr. CAGR %	11.58	5.39	-16.14	9.25	11.87
Capital Expenditures, 2 Yr. CAGR %	-16.23	5.83	0.52	-15.24	-1.9
Levered Free Cash Flow, 2 Yr. CAGR %	43.54	-6.69	-7.16	20.86	-5.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	39.41	-6.38	-6.91	19.52	-5.12
Dividend Per Share, 2 Yr. CAGR %	6.16	3.61	2.78	2.7	2.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.26	6.71	3.17	1.74	2.57
Gross Profit, 3 Yr. CAGR %	8.03	6.75	0.16	1.1	2.39
EBITDA, 3 Yr. CAGR %	7.21	6.78	0.15	-1.28	3.69
EBITA, 3 Yr. CAGR %	7.07	6.74	-0.03	-1.44	3.66
EBIT, 3 Yr. CAGR %	6.31	5.53	-3.65	-3.61	2.5
Earnings From Cont. Operations, 3 Yr. CAGR %	4.33	-5.23	298.05	-57.38	23.06
Net Income, 3 Yr. CAGR %	4.5	-5.18	258.45	-57.44	22.83
Normalized Net Income, 3 Yr. CAGR %	5.07	4.09	-3.24	-2.98	3.13
Diluted EPS Before Extra, 3 Yr. CAGR %	5.74	-4.81	258.27	-57.44	23.04
Accounts Receivable, 3 Yr. CAGR %	10.53	10.07	-1.61	-0.54	0.94
Inventory, 3 Yr. CAGR %	25.73	17.8	2.02	1.86	5.59
Net Property, Plant and Equip., 3 Yr. CAGR %	12.23	4.97	1.66	1.54	0.87
Total Assets, 3 Yr. CAGR %	2.19	0.83	-3.16	-4.6	-2.24
Tangible Book Value, 3 Yr. CAGR %	138.25	51.17	-19.68	-24.46	-45.46
Common Equity, 3 Yr. CAGR %	-0.5	-1.94	7.85	-2.83	2.24
Cash From Operations, 3 Yr. CAGR %	10.66	-0.26	-0.67	-1.66	3.37
Capital Expenditures, 3 Yr. CAGR %	-14.43	-4.08	-3.45	-3.33	-8.21
Levered Free Cash Flow, 3 Yr. CAGR %	14.31	11.58	3.35	-0.24	2.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.01	10.23	3.03	-0.27	2.85
Dividend Per Share, 3 Yr. CAGR %	7.6	5.03	3.32	2.74	2.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.12	0.88	4.15	5.08	3.58
Gross Profit, 5 Yr. CAGR %	-3.58	-0.1	4.08	4.83	2.03
EBITDA, 5 Yr. CAGR %	-7.21	-3.23	3.1	4.61	3.22
EBITA, 5 Yr. CAGR %	-7.51	-3.42	2.94	4.51	3.18
EBIT, 5 Yr. CAGR %	-9.17	-4.92	1.06	2.74	1.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-14.39	-0.34	0.55	-38.29	148.95
Net Income, 5 Yr. CAGR %	-14.34	-0.16	0.76	-38.34	133.35
Normalized Net Income, 5 Yr. CAGR %	-10.32	-5.54	1.19	2.1	1.63
Diluted EPS Before Extra, 5 Yr. CAGR %	-13.09	0.73	1.53	-38.21	133.42
Accounts Receivable, 5 Yr. CAGR %	-0.09	4.4	6.97	4.29	0.09
Inventory, 5 Yr. CAGR %	0.39	13.47	17.03	13.15	1.06
Net Property, Plant and Equip., 5 Yr. CAGR %	14.6	12.66	8.04	2.78	1.8
Total Assets, 5 Yr. CAGR %	3.59	-2.11	-0.49	-0.87	-2.91
Tangible Book Value, 5 Yr. CAGR %	18.83	81.22	50.77	14.08	-35.41
Common Equity, 5 Yr. CAGR %	2.21	0.77	1.32	-3.01	4.52
Cash From Operations, 5 Yr. CAGR %	-7.76	-5.28	-0.96	3.44	4.17
Capital Expenditures, 5 Yr. CAGR %	-4.99	4.29	-8.74	-8.71	-2.83
Levered Free Cash Flow, 5 Yr. CAGR %	-6.31	-8	5.01	15.2	-1.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	-5.98	-7.7	4.42	13.86	-0.95
Dividend Per Share, 5 Yr. CAGR %	9.07	7.02	5.64	4.1	3.04